BioMarin Q3 non-GAAP diluted EPS rises 92% to $0.23
BioMarin Pharmaceutical reported third-quarter non-GAAP diluted EPS of $0.23, up 92%.
Story updates
09:29:36 PM UTC
SquawkNews
04:25 PM EST, 11/02/2026 (MT Newswires) -- BioMarin Pharmaceutical (BMRN) reported Q3 non-GAAP earni